Cognitive-behavioral therapy focused on inhibitory learning, for adults with avoidant/restrictive food intake disorder (ARFID): Study protocol of a prospective study

Malou Masereel, Sebastian Cardona Cano, Trung Dung Tran, Margo de Jonge, Eric Dumont, Annemarie A van Elburg, Sandra Mulkens · 2026

Read Cognitive-behavioral therapy focused on inhibitory learning, for adults with avoidant/restrictive food intake disorder (ARFID): Study protocol of a prospective study by Malou Masereel, Sebastian Cardona Cano, Trung Dung Tran, Margo de Jonge, Eric Dumont, Annemarie A van Elburg, Sandra Mulkens (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354232.txt.

Introduction

Malou Masereel and six colleagues published this 2026 study protocol for treating adults with avoidant and restrictive food intake disorder, a pattern of severely limited eating not driven by body image. No proven treatment exists yet. Their plan, run across eleven Dutch centers, gives about a hundred and twenty patients weekly therapy built on gradual exposure to feared foods.

Severity interviews anchor the checks before treatment, after it, and months later, while session notes track fear and expectations. Because there is no comparison group, Masereel presents the trial as groundwork for later controlled studies and sharper therapy design.

Catalog record

CREATORMalou Masereel, Sebastian Cardona Cano, Trung Dung Tran, Margo de Jonge, Eric Dumont, Annemarie A van Elburg, Sandra Mulkens
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31655
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0354232

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Cognitive-behavioral therapy focused on inhibitory learning, for adults with avoidant/restrictive food intake disorder (ARFID): Study protocol of a prospective study Malou Masereel, Sebastian Cardona Cano, Trung Dung Tran, Margo de Jonge, Eric Dumont, Annemarie A van Elburg, Sandra Mulkens ABSTRACT Objective: Currently, there are no evidence-based treatments available for adults with avoidant/restrictive food intake disorder (ARFID). The present paper describes the design of a study evaluating a cognitive-behavioral therapy (CBT) protocol for adults with ARFID, with a focus on exposure using inhibitory learning principles. Method: This multicenter study uses a prospective, uncontrolled, repeated-measures design. A total of 120 adults (aged ≥ 18 years) with ARFID will be included via 11 participating treatment centers throughout the Netherlands. Participants will receive a manualized treatment of 25 weekly sessions. Assessments will be conducted at baseline, post-treatment, and at 1- and 12-month follow-ups. The primary outcome is ARFID severity, measured by the Pica, ARFID, and Rumination Disorder Interview (PARDI). Session-level measures of fear and expectancies will be collected throughout the treatment to explore potential mechanisms of change. Treatment effects will be examined across ARFID profiles and comorbid disorders. Discussion: This is the first large-scale study to investigate an outpatient CBT program for adults with ARFID. By examining outcomes across ARFID profiles and exploring underlying mechanisms of change, the findings are expected to inform treatment refinement and provide a foundation for future controlled trials. The study has been preregistered in AsPredicted (#212,212) and the trial was registered in the Overview of Medical Research in the Netherlands (NL-OMON6121). Introduction In 2013, avoidant/restrictive food intake disorder (ARFID) was introduced to the chapter of feeding and eating disorders in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) [ 1 ]. ARFID refers to a feeding and eating disorder which is characterized by insufficient and/or highly selective food intake, with significant consequences for physical and/or psychosocial wellbeing. Unlike other eating disorders, ARFID is not driven by concerns about body weight or shape. The DSM-5-TR [ 2 ] describes three non-mutually exclusive profiles regarding the drivers for avoidance and/or restriction: (1) avoidance based on the sensory characteristics of food (such as taste, smell, color, and texture); (2) a lack of interest in food or eating; and (3) avoidance based on concern over aversive consequences of eating (e.g., choking, gastrointestinal discomfort, or vomiting). Common psychiatric comorbidities with ARFID include anxiety disorders, neurodevelopmental disorders such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and intellectual disability (ID), as well as mood disorders [ 3 – 5 ]. Somatic comorbidities such as gastrointestinal (GI) symptoms and disorders, metabolic diseases and syndromic disorders are also commonly observed [ 3 , 6 – 8 ]. ARFID can occur across the lifespan, with prevalence estimates in the general adult population ranging from 0.3% to 4.8% [ 9 – 13 ]. A recent quality-effects meta-analysis that included both clinical and non-clinical samples, found comparable prevalence rates among children (4.73%) and adults (5.9%) [ 14 ]. Despite this, evidence-based treatments for adults with ARFID are lacking. Most knowledge about treatment effectiveness to date comes from research in children, most of it conducted before ARFID was introduced as a formal diagnosis in the DSM-5 [ 1 ]. For young children with ARFID, behavioral interventions are commonly used, often utilizing strategies like shaping, escape extinction, reinforcement, and systematic desensitization [ 15 – 18 ]. However, these treatment programs are less suitable for adolescents and adults because of the child-focused approach and the lack of consideration for cognitive processes. For this age group, cognitive behavioral therapy (CBT) might be more appropriate. CBT is a well-established and evidence-based treatment for other eating disorders such as bulimia nervosa and binge eating disorder [ 19 – 22 ]. Moreover, CBT is currently used to treat ARFID in clinical practice, and a small number of case studies and case series have examined its application in adolescents (aged 10 years and older) and adults [ 15 ]. Dumont and colleagues [ 23 ] developed a four-week CBT group intervention for adolescents within an intensive day care, tertiary treatment setting. The treatment protocol includes several CBT components, such as psychoeducation, relaxation techniques, and cognitive restructuring. However, its primary focus is on exposure therapy, with an emphasis on expectancy violation, consistent with the inhibitory learning approach [ 24 ]. The intervention does not tailor its approach based on the ARFID profiles. Instead, the authors argue that expectancy violation can be possible across all ARFID presentations, even those not primarily driven by anxiety, by targeting learned associations such as disgust or aversive physiological responses. They evaluated the treatment in a clinical case series with 11 adolescents aged 10–18 years and found that 3 months post-treatment, 10 out of 11 patients were in remission and achieved a healthy body weight and nutritional intake. Although clinical reports indicate the use of CBT for adults with ARFID, formal evaluation of its effectiveness in this population is lacking. To our knowledge, only one study has investigated a CBT protocol for adults with ARFID. Thomas and Eddy [ 25 ] designed a protocol, ‘CBT-AR’, for children from age 10, adolescents and adults with ARFID. CBT-AR consists of 4 stages, spread out over 20–30 sessions. Unlike the protocol of Dumont and colleagues [ 23 ], CBT-AR tailors treatment based on the ARFID profile, weight status, and age. Thomas et al. [ 26 ] investigated the protocol in 14 adults aged 18–55 years. They found that ARFID severity decreased significantly from pre- to post-treatment and that 47% of the patients no longer met criteria of ARFID immediately after the treatment. While both the CBT-AR protocol [ 26 ] and the day-treatment protocol by Dumont et al. [ 23 ] have shown promising results in terms of feasibility and effectiveness, studies with larger sample sizes and longer follow-up periods are still needed. Moreover, the treatment protocol developed by Dumont and colleagues has not yet been evaluated in an adult population, nor has its applicability been examined in a less intensive, secondary care setting. Therefore, the present study aims to evaluate an adapted version of this protocol, modified for adult patients and delivered in an outpatient, secondary care, individual format. The present study aims to evaluate a 25-session outpatient CBT protocol for adults with ARFID using a multicenter, prospective, one-group design. We will assess changes in ARFID severity from pre- to post-treatment, as well as the stability of these changes during a follow-up period of one year (research question 1). Additionally, we will examine whether treatment effects differ across the three ARFID profiles (research question 2) and whether potential comorbidity affects the outcomes (research question 3). Finally, we will investigate whether underlying mechanisms of change are better explained by habituation or expectancy learning (research question 4). Method Participants We aim to include 120 patients across 11 specialized treatment centers for eating disorders throughout the Netherlands. Eligible patients who receive an ARFID diagnosis in one of the centers, will be informed both orally and through a written information letter. After receiving the study information, they will be provided with the option to fill in their contact information via a QR code. Then, after a one-week consideration period, the researchers will contact the participant and send a

Read the complete text